Financials
- Market Capitalization 174.51 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.equilliumbio.com
- Headquarter Delaware, United States
- FIGI BBG00LSL8C10
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.52
Rapporto prezzo/fatturato
203.81
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3706 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 11.06 USD | -5.55% | -12.91% | -5.63% | -26.32% | 176.31 M USD | ||
| 3711 | ACOG Alpha Cognition Inc. - Common Stock | 8.05 USD | -3.94% | -0.62% | +32.40% | -24.34% | 175.28 M USD | ||
| 3719 | CRBU Caribou Biosciences, Inc. - Common Stock | 1.75 USD | -2.78% | -7.41% | +5.42% | +5.42% | 173.57 M USD | ||
| 3727 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.76 USD | +4.62% | +14.15% | -3.45% | +349.06% | 171.44 M USD |